Results

Total Results: 2,890 records

Showing results for "disease".

81. Heart Valve Diseases | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/heart-valve-diseases/

82. Surgical Management of Cervical Degenerative Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/cervical-degenerative-disease
    June 11, 2021 - Description Date submitted: June 11, 2021 Surgical Management of Cervical Degenerative Disease … and clinically relevant evidence for the surgical management of patients with cervical degenerative disease … Cervical degenerative disease is the most common cause of acquired disability in patients over the age … For patients with ≥3 levels of disease, is posterior surgery associated with better outcome and fewer … Adjacent segment disease and pseudarthrosis 1.

83. Screening for and Management of Chronic Kidney Disease Stages 1-3 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/research-protocol
    July 28, 2010 - First, CKD shares many of the same risk factors as other vascular diseases, such as older age, hypertension … Causes of CKD can be broken down into primary kidney diseases (predominantly glomerular diseases, tubulointerstitial … diseases, obstruction, and polycystic kidney disease) versus those in which the kidney damage is secondary … (e.g., coronary artery disease [CAD], peripheral arterial disease [PAD], cerebrovascular disease [CVD … and kidney disease.

84. SEAD Submission Form for Cervical Degenerative Disease Treatment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/form/cervical-degenerative-disease/sead

85. Noninvasive Testing for Coronary Artery Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/coronary-artery-disease-testing/research
    March 29, 2016 - 15, 2015 Research Protocol Mar. 29, 2016 Systematic Review Noninvasive Testing for Coronary Artery Disease … regarding effectiveness and harms of noninvasive technologies for the diagnosis of coronary artery disease

86. Treatment Strategies for Patients With Peripheral Artery Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-treatment/research
    May 29, 2013 - 12, 2013 Disposition of Comments Report Treatment Strategies for Patients With Peripheral Artery Disease … Structured Abstract Objectives For patients with peripheral artery disease (PAD), the optimal treatment … Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease

87. Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-effectiveness/abstract
    February 08, 2011 - Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease … Abstract Archived February 8, 2011 Topic Abstract Background Peripheral arterial disease … A retrospective clinical registry of patients with peripheral arterial disease (PAD) will assess the

88. Cervical Degenerative Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cervical-degenerative-disease/draft-comments

89. Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/renal-disease-iron
    January 24, 2012 - Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease … Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease

90. Pharmacological Management of Crohn's Disease: Future Research Needs | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/crohns-disease-future
    April 02, 2014 - Pharmacological Management of Crohn's Disease: Future Research Needs Timeline February … 02, 2014 Systematic Review Archived Pharmacological Management of Crohn's Disease

91. Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage Renal Disease | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/renal-disease-therapies
    March 31, 2011 - Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage … Renal Disease Timeline March 31, 2011 Topic Initiated March 31, … Archived Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease … Outcomes In End-Stage Renal Disease

92. Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-Stage Renal Disease (ESRD) | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/renal-disease-anemia
    March 31, 2011 - Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in … End-Stage Renal Disease (ESRD) Timeline March 31, 2011 Topic Initiated … Archived Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease … Outcomes in End-Stage Renal Disease (ESRD)

93. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
    January 01, 2014 - (JAK-3) signaling pathway believed to mediate several processes involved in chronic inflammatory diseases … (JAK-3) signaling pathway believed to mediate several processes involved in chronic inflammatory diseases … reduce the B cells responsible for autoantibody production in SLE and potentially other autoimmune diseases … Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008;10(5):223. … Connective tissue diseases: Belimumab for systemic lupus erythematosus: breaking through?

94. Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/

95. Cervical Degenerative Disease Treatment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cervical-degenerative-disease

96. Peripheral-Artery-Disease-Treatment Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
    May 01, 2013 - represents a spectrum of disease severity from asymptomatic disease to intermittent claudication ( … Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. … Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. … Lower limb peripheral arterial disease: diagnosis and management. … Treatment Strategies for Patients With Peripheral Artery Disease.

97. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - The National Institute of Arthritis and Musculoskeletal and Skin Diseases estimates that almost 27 … (JAK) signaling pathways believed to mediate several processes involved in chronic inflammatory diseases … kinase (JAK) signaling pathways believed to mediate several processes involved in chronic inflammatory diseases … needed to maintain control of the disease. … Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008;10(5):223.

98. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - Arthritis and Nontraumatic Joint Disease AHRQ Healthcare Horizon Scanning System – Potential High-Impact … Interventions Report Priority Area 01: Arthritis and Nontraumatic Joint Disease Prepared … 27 million Americans according to the National Institute of Arthritis and Musculoskeletal and Skin Diseases … Treatment options for cervical degenerative disc disease. [internet]. … Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10(5):223.

99. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
    January 01, 2012 - The National Institute of Arthritis and Musculoskeletal and Skin Diseases estimates that almost 27 … kinase-3 signaling pathway believed to mediate several processes involved in chronic inflammatory diseases … 3 (JAK3) signaling pathway believed to mediate several processes involved in chronic inflammatory diseases … needed to maintain control of disease. … Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008;10(5):223.

100. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Arthritis and Nontraumatic Joint Disease AHRQ Healthcare Horizon Scanning System – Potential High-Impact … Interventions Report Priority Area 01: Arthritis and Nontraumatic Joint Disease Prepared … Priority Area 01: Arthritis and Nontraumatic Joint Disease Topic High-Impact Potential 1. … million Americans, according to the National Institute of Arthritis and Musculoskeletal and Skin Diseases … Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10(5):223.